Korea: Innovation & R&D Trends

This session will focus on the latest developments in the Korean biopharmaceutical market and look in-depth at R&D trends. Korea has emerged as a leading biopharmaceutical market, valued at around $18.6 billion with a annual growth rate of 7% from 2012 to 2018. Furthermore, the domestic biopharmaceutical industry is expanding internationally with the advancement of innovative technologies and has become a key growth engine for the Pharma industry in Korea. hear from global consultants on the strengths of Korea's Biopharma industry, who will share practical information and data on R&D, RA, Business Development and Marketing strategies. This is a great opportunity to gain cutting-edge insight from businesses who are scaling up for the future and building partnerships with domestic pharmaceutical companies. - Peptron : Smart Depot Platform and its applications - Olix Pharmaceuticals : OliX Pharmaceuticals: RNAi Therapeutics Company - HK inno.N : World P-CAB Leader, HK inno.N - Daewoong Pharmaceutical : Research & Development innovation with Daewoong's Platform Technology - Huons : Huons Corporate Presentation: Hu007 and Hutox - Ceres F&D : Introduction of Hyaluronidase and Tacrolimus